Chuang, Emil <br/><br/>
Biomedicines to reduce inflammation but not viral load in chronic HCV--what's the sense?  [electronic resource] 

 -  Trends in biotechnology  Oct 2004 
 - 517-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0167-7799 
<br/><br/><label>Standard No.: </label>10.1016/j.tibtech.2004.08.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammation--drug therapy<br/>Infliximab<br/>Liver Cirrhosis--drug therapy<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Viral Load